Health care special purpose acquisition companies in 2020-2021 represented a temporary market inefficiency that enabled weaker companies to bypass traditional due diligence and ultimately led to failures.

November 7th, 2026

Machine Learning to Target Procalcitonin Testing

Machine learning prediction of procalcitonin positivity using inexpensive routine laboratory tests may reduce procalcitonin test volume and support diagnostic stewardship.

November 7th, 2026

Well-Child Visits After Adoption of an Equity-Focused Payment Incentive in Medicaid

After Pennsylvania began rewarding Medicaid managed care plans for increasing well-child visits among Black infants, rates did not change significantly overall but varied by region.

November 6th, 2026

Exploring the Links Between 340B Growth and Overall Health Care Spending

Greater 340B activity—measured by county-level hospital child sites and contract pharmacy arrangements—was associated with significantly higher county-level total and out-of-pocket health care spending.

November 6th, 2026

Midterms Signal Changes to Committees That Govern Cancer Care

The associate editor of Evidence-Based Oncology says the turnover that will follow this week's midterm election calls for renewed engagement from community oncology leaders with members of Congress, due to pressing reimbursement issues.

Using Evidence-Based Techniques to Modify Anemia Screening Practice

Articles in this issue

Related to this article

Trending on AJMC

FDA Approves Asundexian, First FXIa Inhibitor to Prevent Repeat Stroke

How Plans, Clinicians Should Handle Gray-Market Retatrutide

IVF Beats IUI for Early Live Births in Unexplained Infertility

Early-Onset Cancers Often Found Late as Screening Gaps Persist

AHIP's Jeanette Thornton on Prior Authorization Reform, Midterms